SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001167966-05-000369
Filing Date
2005-03-15
Accepted
2005-03-15 16:23:23
Documents
11
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 THERAGENICS CORPORATION FORM 10-K t5202_10k.htm 10-K 1569012
2 ADDITIONAL COMPENSATION INFORMATION ex10-19.htm EX-10.19 7786
3 SHORT-TERM INCENTIVES ex10-20.htm EX-10.20 12198
4 LONG-TERM INCENTIVES ex10-21.htm EX-10.21 25592
5 FORMS OF OPTION AWARD ex10-22.htm EX-10.22 217509
6 FORM OF RESTRICTED STOCK AWARD ex10-23.htm EX-10.23 49771
7 CONSENT ex24-1.htm EX-24.1 3490
8 CERTIFICATION ex31-1.htm EX-31.1 15437
9 CERTIFICATION ex31-2.htm EX-31.2 14976
10 CERTIFICATION ex32-1.htm EX-32.1 6257
11 CERTIFICATION ex32-2.htm EX-32.2 6403
  Complete submission text file 0001167966-05-000369.txt   1931236
Mailing Address 5203 BRISTOL INDUSTRIAL WAY BUFORD GA 30518
Business Address 5203 BRISTOL INDUSTRIAL WAY BUFORD GA 30518 7702710233
THERAGENICS CORP (Filer) CIK: 0000795551 (see all company filings)

IRS No.: 581528626 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14339 | Film No.: 05681982
SIC: 2834 Pharmaceutical Preparations